Home › Two experimental Ebola vaccines pass safety test in African trial
 

Keywords :   


Two experimental Ebola vaccines pass safety test in African trial

2015-03-27 00:17:51| Biotech - Topix.net

Two experimental Ebola vaccines, one from GlaxoSmithKline PLC and the other from biotech start-up NewLink Genetics Corp, "appear to be safe" part way through a clinical trial being conducted in Liberia, the U.S. National Institutes of Health said on Thursday. The two vaccines, each given in a single injection, are being tested for safety and efficacy on more than 600 people in Liberia in a mid-stage clinical trial sponsored by the National Institute of Allergy and Infectious Diseases, a branch of NIH.

Tags: test safety pass trial

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.06Atlantic Tropical Weather Outlook
28.06Learning to listen to nursery pigs
28.06Incomes have risen 'at a crawl' says think tank
28.06Eastern North Pacific Tropical Weather Outlook
28.06Are rainy days ahead for cloud computing?
28.06Electric car battery charges in under five minutes in track test
28.06Debt relief orders can write off up to 50,000
27.06Strike could force Tata plant to shut next week
More »